Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell therapy versus chemotherapy

INTRODUCTION: Chimeric antigen receptor (CAR) T-cell (CAR-T) therapy followed by haploidentical hematopoietic stem cell transplantation (haplo-HSCT) markedly improves the long-term survival of patients with refractory/relapsed (R/R) B-cell acute lymphoblastic leukemia (B-ALL). METHODS: We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ting-Ting, Meng, Ye, Kong, De-Lin, Wei, Guo-Qing, Zhang, Ming-Ming, Wu, Wen-Jun, Shi, Ji-Min, Luo, Yi, Zhao, Yan-Min, Yu, Jian, Jing, Rui-Rui, Zhao, Meng-Yu, Zhao, Hou-Li, Huang, He, Hu, Yong-Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468760/
https://www.ncbi.nlm.nih.gov/pubmed/36110859
http://dx.doi.org/10.3389/fimmu.2022.934442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468760/
https://www.ncbi.nlm.nih.gov/pubmed/36110859
http://dx.doi.org/10.3389/fimmu.2022.934442

Ejemplares similares